The Study of Conbercept and Vitrectomy Combined with Phacoemulsification in the Treatment of PDR with Cataract

doi:10.7517/issn.1674-0475.211110

Abstract

Abstract: This study investigated the clinical effect of conbercept and vitrectomy combined with phacoemulsification in patients with proliferative diabetic retinopathy (PDR) complicated with cataract. Chosen 120 patients (120 eyes) with PDR complicated with cataract as the research objects, and divided them into the experimental group and the control group with 60 cases in each group through random number table. Three and six months after operation the BCVA values of experimental group were both less than those of control group (P＜0.05). Preoperative and postoperative 1, 3, 6 months there was no significant difference between the two groups in the astigmatism of the operated eyes (P＞0.05). After 1 month operation the intraocular pressure of the experimental group was lower than control group (P＜0.05). Compared with the measured values of foveal retinal thickness after 1, 3, 6 months, the experimental group was lower than those of control group (P＜0.05). The incidence of anterior chamber inflammation in the experimental group was 11.67% and lower than 30.00% in control group (P＜0.05). Conbercept, vitrectomy combined with phacoemulsification have a better visual improvement effect than without conbercept in the treatment of PDR combined with cataract. At the same time the correction effect of the postoperative foveal retinal thickness shows better and the incidence of postoperative anterior chamber inflammation was lower.

Key words: conbercept, phacoemulsification, cataract, diabetic retinopathy, anterior chamber inflammation, vitrectomy

LI Caibao, JIANG Huimin, XU Wanxin. The Study of Conbercept and Vitrectomy Combined with Phacoemulsification in the Treatment of PDR with Cataract[J]. IMAGING SCIENCE AND PHOTOCHEMISTRY, 2022, 40(3): 485-489.

References

[1] 梁泽玉, 陈松, 何广辉, 等. 术前及术中2次应用康柏西普辅助玻璃体切割术治疗增生型糖尿病视网膜病变的临床研究[J]. 眼科新进展, 2019,39(2):162-167.
[2] Sun D F, Wang Y L, Wang B, et al. Predictive risk factors for exudative retinal detachment after vitrectomy for proliferative diabetic retinopathy[J]. Medicine, 2019,98(8):e14603.
[3] 《中国糖尿病防治指南》编写组. 中国糖尿病防治指南[J]. 北京:北京医科大学出版社, 2004.
[4] 周莉, 许荣, 王勇, 等. 同轴微切口扭动超声乳化吸除术治疗硬核白内障的临床评估[J]. 国际眼科杂志, 2013,13(9):1772-1774.
[5] 曾广川, 廖许琳, 李萍萍, 等. 玻璃体腔联合前房注射康柏西普对新生血管性青光眼的辅助治疗作用[J]. 检验医学与临床, 2019,16(22):3266-3268, 3272.
[6] 张燕, 冯劼, 鲁铭, 等. 康柏西普在糖尿病性白内障患者超声乳化术中的应用[J]. 眼科新进展, 2019,39(11):1052-1055.
[7] 姚永屿, 夏鸿慧, 范卫, 等. 玻璃体腔内注射康柏西普联合玻璃体切除术治疗增殖性糖尿病视网膜病变疗效观察[J]. 海南医学, 2019,30(7):868-871.
[8] Yu X W, Zhao Z N, Zhang D D, et al. Anterior vitrectomy, phacoemulsification cataract extraction and irido-zonulo-hyaloid-vitrectomy in protracted acute angle closure crisis[J]. International Ophthalmology, 2021,41(9):3087-3097.
[9] 林红, 孙常丽, 骆洪梅, 等. 康柏西普术前、术中辅助玻璃体切除术治疗增生型糖尿病视网膜病变的临床效果观察[J]. 临床眼科杂志, 2019,27(5):399-403.
[10] Naruse Z, Shimada H, Mori R. Surgical outcomes of 27-gauge and 25-gauge vitrectomy day surgery for proliferative diabetic retinopathy[J]. International Ophthalmology, 2019,39(9):1973-1980.
[11] 李玉红, 马凌葵. 玻璃体切除术同期联合白内障超声乳化吸除术治疗PDR[J]. 国际眼科杂志, 2019,19(3):474-476.
[12] Noh H J, Kim S T. Combined treatment of phacoemulsification and single-port limited pars Plana vitrectomy in acute angle-closure glaucoma[J]. International Journal of Ophthalmology, 2019,12(6):974-979.
[13] 储昭节, 王彤, 潘小燕, 等. 康柏西普辅助玻璃体切除联合人工晶体植入手术与序贯手术治疗增殖性糖尿病视网膜病变对比研究[J]. 陕西医学杂志, 2019,48(7):870-872.
[14] 李双, 项奕, 梅仲明. 玻璃体腔注射康柏西普治疗糖尿病性黄斑水肿的疗效[J]. 中国老年学杂志, 2019,39(21):5198-5201.
[15] 李瑾, 张胜娟, 赵伟, 等. 视网膜静脉阻塞合并黄斑水肿抗VEGF治疗后黄斑中心凹无血管区的变化[J]. 临床眼科杂志, 2019,27(1):16-19.